LicianPro

NREF earnings / call

NREF earnings call transcript, November 5, 2026

NexPoint Real Estate Finance Q3 2026 Earnings Call

ReplayOfficial webcast

Key takeaways from this call : results vs expectations, guidance, what analysts asked

  • Matt 46%
  • Management 19%
  • Carly Musser 6%
  • Paul Richards 1%
  • Analysts 1%

Management

  • Matt

    Management

    11 min

  • Carly Musser

    Management

    1 min

  • Paul Richards

    Management

    <1 min

Analysts · 1

Transcribed automatically by Lician from the company's public webcast; it can contain errors and speaker names are best effort.

  1. Prepared remarks0:02
  2. Thank you for joining us and welcome to Next Point Real Estate Finance Q3 2026 earnings call. After today's prepared remarks, we will host.

  3. Operator

    A question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Carly Musser with communications and corporate affairs. Carly, please. Go ahead.

  4. Carly MusserManagement

    Thank you, Caleb.

  5. Good morning and welcome to NextPoint Real Estate Finances conference call to review the company's results for the third quarter ended September 30th, 2026. Today are Paul Richards, Executive Vice President and Chief Financial Officer, and Matt McGriner, Executive Vice President and Chief Investment Officer. As a reminder, this call is being webcast through the company's website at nres.net. Before we begin, I would like to remind everyone that this conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management. Current expectations, assumptions, and beliefs. Listeners should not place undue reliance on any forward-looking statements and are encouraged to review the company's annual report on Form 10-K and the company's other filings with SEC for a more complete discussion of risks and other factors that could affect the forward-looking statement. The statements made during this conference call speak only as of today's date and accept as required by law. NREF does not undertake any obligation to publicly up date or revise any forward-looking statements. This conference call also includes an analysis of non-GAAP financial measures. For a more complete discussion of these non-GAAP financial measures, see the company's presentation that was filed earlier today. I would now like to turn the call over to Paul Richards. Please go ahead, Paul.

  6. Paul RichardsManagement

    Thanks, Carly, and good morning, everyone. I'll walk through our quarterly results, cover the balance sheet, and provide guidance for Q4 before turning it over to Matt for a deeper dive on it.

  7. MattManagement

    For the third quarter, we reported a net loss of $0.65 per diluted share, compared to $1.14 for Q3 2025. Earnings available for distribution was $0.52 per diluted share in Q3 2025. Compared to $0.51 per diluted share in the same period of 2025. Cash available for distribution was $0.60 per share in Q3, compared to $0.53 per diluted share in the same period of 2025. We paid a regular dividend of $0.50. $0.50 per share in the third quarter, which is 1.2 times covered by the cash available for distribution. On October 26, 2026, the Board declared a dividend of $0.50 per share payable for the fourth quarter of 2026. Value per diluted share decreased 5.2% from Q2 2026 to $17.63 per diluted share, primarily driven by unrealized losses on a few of our fair value positions due to a rapid rise in rates over the quarter, which has subsequently retraced and rallied back a substantial amount, which we believe should assist in a mark rebound. Turning to new investments during the quarter, we have continued to originate new investments across our target asset classes, funded through a combination of retained operating cash flow, proceeds from our series C preferred offering, and additional capacity under our secured financing facilities, reflecting our continued ability to identify next. Attractive opportunities that drive returns for shareholders. We funded a $4 million preferred equity investment in a multifamily property that pays a monthly coupon of 14%, a 2.2 million preferred equity investment in a marina at a 13% coupon and funded an additional 91.7 million on other exist.

  8. commitments in the quarter. During the quarter, we upsized our 375 million term loan facility and total return swap with Mizuho capital markets to 450 million, which we use to fund existing commitments, primarily an 80.5 million bridge. loan yielding 40% that paid off at the end of the quarter. In accordance with the payoff, we paid down 52.2 million on the secured facility, lowering total outstanding balance at 397.8 million. Combined with the 27. million be raised and are seriously preferred. We head into the last quarter of 2026 with what we believe to be one of the cleanest, most flexible capital structures in the commercial mortgage sector. Our portfolio is comprised of 83 investments with a total outstanding balance of one. Billion dollars. Our investments are allocated across sectors as follows. 40.7% life sciences, 38.3% multifamily, 14% single family rental, 4.6% storage, 2.2% industrial, and 0.2% marina. Our fixed income portfolios. Allocated across investments as follows. 28.4% preferred equity investments, 22.8% mezzanine loans, 18.2% revolving credit facilities, 17.9% CNBSB pieces, 6. 3.4% senior loans, 3.9% IO strips, and 2.3% promissory notes. The assets collateralizing our investments are allocated geographically as follows. 31.1% Massachusetts, 15. 18% Texas, 7% North Carolina, 6.5% Florida, and 5.5% California, with the remainder across states with less than 5% exposure, reflecting our heavy preference for sunbelt markets with Massachusetts and California exposure heavily weighted towards life science.

  9. The collateral on our portfolio is 78.3% stabilized with 64.7% loan-to-value and a weighted average DSDR of 1.39 times. We have $913.1 million of data outstanding with a weighted average cost of 5.8% and has a weighted average maturity of 2.5 years. Our secured debt is collateralized by $1.5 billion of collateral with a weighted average maturity of 2.6 years and a debt-to-equity ratio of 0.97 times. Moving to guidance for the fourth quarter. Earnings available for distribution. $0.42 per deluded share of the Bitcoin with a range of $0.36. $0.37 on the low end and $0.47 on the high end. Cash available for distribution. $0.55 per deluded share at the midpoint with a range of $0.50 on the low end and $0.60 on the high end. With that, I'd like to turn it over to Matt for a detailed discussion of the portfolio and the current market environment. Matt. Thank you, Paul. This quarter was a solid, consistent.

  10. Execution, both EAD and CAAD came in ahead of our guidance and given our positive credit profile and the improving but still challenging macro backdrop, we continue to play offense in this environment and expect opportunities for our solution-oriented capital to grow over the near term. Matt. The Fed has. held its target rate at 3.75% to 4% in late October and the 10-year Treasury moved back above 5% higher for longer pressures borrowers who need to refinance or meet extension tests. And this, and that is exactly where discipline. Solution capital earns its pricing power. Our new investments are priced at double digit coupons at reset basis, and therefore we believe we are well positioned for this type of environment. Now turning to our verticals residential between multi and. Single family rental remain remains our largest exposure. Our multifamily credits. It's predominantly behind agency underwritten senior debt, which has historically been some of the most resilient collateral in real estate. Freddie Mac's aggregate losses have averaged. About seven basis points per year since 2009 with 432.6 million of cumulative losses on 645.8 billion of issuance through August of 2026. That's not to say there's not stress in the system, though. Trev has Freddie's multifamily delinquency at 80 basis points of UPB in August, up from 48 basis points in August of 2024. We see this as an opportunity.

  11. Which I'll elaborate on in a minute. On the supply side, multifamily construction starts fell more than 40% between 2023 and 2025, and new deliveries are forecasted to bottom near 327,000 units in 2027. Well below the roughly 600,000 unit peak in 2024. Supply is what broke pricing power the last two years, and the falling supply pipeline is what we expect to restore it. That said, the recovery is not linear, and in the third quarter, for blended lease rates across our portfolios remain flat to slightly positive, and concessions, while abating, are still prevalent in the market for Class A and Class B multifamily in our geographical geographical footprint. The good news is we are underwriting and deploying our capital into new residential investments on today's rents, again on a reset basis and not on a recovery pro forma. Our single family rental book continues to perform really well with significant equity cushion. Overall, we view the sector's building. Profile is slightly more favorable than multifamily with rents already in positive territory and less pockets of distress. The number of households renting single family homes continue to rise and higher for longer should keep demand high for our affordable. SFR in our markets. Now on to life science. At Alewife, the sponsors recap process is underway and we continue to expect a substantial, if not all, of our return of capital in the next quarter or two.

  12. When the capital comes back, our plan is to redeploy most of it into residential, residential collateral and move into move life science back toward roughly the one third of the portfolio over time. Across the rest of our life science exposure. Fundamentals continue to improve sequentially, particularly in Boston and San Francisco, with 220,000 square feet of new leases signed during the year today, the remaining industry industry wide speculative pipelines is expected to deliver. Through 2026, after which new supply will be limited largely to fully fully preleased build the suit projects. Demand is broadening beyond traditional lab users to biomanufacturing on shoring and AI driven users that need. Power density, floor loads, and lab grade infrastructure. Importantly, and again, most of this book was originated in 2025 through 2026 at a reset basis. In self-storage fundamentals troughed in 2025. And with new construction pipelines well below historical averages, we expect conditions to keep strengthening. During the quarter, we continued to add small mezzanine positions on newly stabilized storage assets at double-digit coupons. The sector has already largely reported better than expected results during the quarter, and our NSP-owned portfolio continues to perform very well. With occupancy as of 9.30 at 93.5% and rents up 600 basis points year-over-year. On the pipeline in April, we outlined more than $190 million of NREF investments and more than $225 million of structured product opportunities. Year-to-date, I'm pleased to see you next time.

  13. Let's say we have closed $280 million of that $415 million pipeline and have another $160 million committed over the next 12 months with an active pipeline backlog building. We were deliberately selected in the third quarter, and with the additional Mizuho capacity and expected repayments, we have the dry power. to lean in at attractive spreads in the fourth quarter and into 2027, and I'm glad we waited on some of the resi opportunities because more will appear. One critical need for the market will be will be to provide solution and special situation capital for the rest. And this is a great opportunity for NREF over the next couple of years, but the caveat that it might not fully materialize if the capital markets rapidly improve, which we wouldn't hate either. The stress in agency multifamily is concentrated. Floating rate loans originated in 2020 through 2023 when SOFR was near zero. Those loans need replacement rate caps, cap escrows, and in many cases, a pay down to meet their refi and extension tests, and a meaningful number of sponsors do not have the equity to do it. In agency rate, in agency floating rate securitizations alone, that vintage is more than $32 billion across roughly 1,000 loans, and about a quarter of that balance is already on special service or watch list. We have demonstrated time and time again that we can be a creative partner with the agencies, particularly FREDDIE, to provide solution-oriented capital on a bespoke basis. We're already developing a program where NREF would provide coterminous supplemental capital behind the existing first lien so that sponsors can buy the cap, fund reserves, and pass their tests rather than

  14. hand back the keys. This is exactly the kind of solution capital we have built a platform around. It sits behind conservatively underwritten agency senior debt and asset class in the markets we know as operators and as price-like rescue cap. We would also expect it to be financed on a match term basis, similar to how our original SFR portfolio was financed. The program is not final, but we do believe there's a strong need for it, and we're excited about it. To close and summarize, we're pleased with where we are, particularly in this year. Earnings came in ahead of guidance. The dividends covered. Credit continues to hold well, and our balance sheet has more capacity than it did a year ago. As always, I want to thank this team for their hard work and focus, and with that, we'd like to turn the call over to the operator and take your questions.

  15. Q&A13:13
  16. Operator

    We will now begin the question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. We ask that you pick up your handset when asking a question to allow for optimum sound quality. If you are a musician, please press star one again. Unmuted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster.

  17. Your first question comes from the line of Jade Rahmani with KBW. Your line is open.

  18. Please go ahead.

  19. Question · KBW

    Jade RahmaniAnalyst · KBW

    Thank you very much.

  20. Could you give an update on the IQHQ exposure, specifically the credit facility and preferred equity position, and how you expect that to perform? Over the next one to two years? Yeah, happy to.

  21. Management

    Good morning.

  22. Management

    So the PREF and the RCF sit at different detachment points, but it's roughly, I think, 350 million collectors. Collectively, the company is, as I've said in the past, you know, executing on its plan, seeing a lot of good traffic in Boston and San Francisco in particular. The kind of near term, I would say. This is Alewife and they're continuing to either recap or monetize and or sell that asset. And so to the extent that it's sold and that frees up a ton of capital to kind of, you know, delever the company and take some of. You know, to take out some of our capital in terms of, you know, the I'd say the the widening funnel, one thing that's that's kind of popped up in the last quarter to these assets have not only really great infrastructure, but they kind of. of unbeknownst to, you know, the sponsor has a great deal of powered shell and what I mean by that is the assets are now starting to get looks for edge compute and then the economics of that are. are pretty stellar. So that's one sort of green shoot that has appeared relatively recently that, you know, I think the team is working on and could be a could could be a pretty interesting monetization event, given where we are in the cycle. But yeah, I think I think our exposure is, you know, from a per square foot. attachment standpoint, some of the best out there. I think the RCF detachment point is roughly, you know, 1100 bucks a square foot. The Series E detachment point is roughly 1350 a square foot. And so if you, you know, you compare

  23. Management

    these to, you know, the rest of the, the industry and particularly, you know, just plain new, you know, new office rents and new office buildings, I think, I think we like where we are in the cap stack. And if Alewife, um, refinance and there is a repayment, would that pay down any of the preferred or credit facility? Yeah, absolutely. Good. Um, the, uh, you know, the, the current or our first, first mortgages, you know, roughly a couple hundred million. Um, I know there, uh, there's term sheets and, and other kind of loan sizing out there in the 400. This range. So, um, yeah, I would expect there to be excess cash there. Okay. And then turning to the rest of the portfolio, um, like the preferred equity and mezzanine exposure to multifamily. How are you feeling about the performance outlook there? Because you did mention that there's significant challenges in, uh, multifamily credit. Um, so I know the vintage is more recent, but if you could comment on that portfolio. Yeah, the, the, the problems that we had, um, were like two. Three loans that we've already taken back and consolidated. Um, you know, one comes to mind was the Alexander project in Atlanta that we, um, took back, I think early last year. Um, that project is now 97% leased, uh, uh, 95% occupied. And doing really well. Um, same thing with, uh, Ridgeview. And then, um, I think another deal called Mag and May, but all of those are, um, that, you know, those were known to us and, and have largely been, you know, um, foreclosed on and, and, and now.

  24. Management

    By us and we're in nursing and back to health, which kind of all told, all told, isn't, um, a ton of exposure. Um, the, the rest of the, you know, the rest of the meds and, uh, and prep positions are, you know, performing well and on, and on schedule and the new, you know, the new construction, um, you know, prep and meds positions, uh. are doing, you know, extremely well in delivering, um, you know, kind of on schedule, on budget, and then, you know, hopefully into an environment in 2029, uh, where there's going to be no new supplies. So, uh, feel, feel really good about, you know, that. Uh, particularly, um, relative to the rest of the commercial, uh, real estate mortgage, uh, REIT universe.

  25. Management

    Thank you very much.

  26. Management

    Thanks, Jay.

  27. Operator

    Your next question comes from the line.

  28. Of Gabe Poggi with Raymond James. Your line is open. Please go ahead.

  29. Hey guys.

  30. Uh, good morning.

  31. Thanks for taking the time.

  32. Um, I want to follow up on a couple specific assets, uh, to press equity. Positions Holly Springs and Vacaville. We've talked about before. It looks like those loans may have been extended. Can you just give us an update on what's going on there? Yeah. Holly Springs is, um, you know, some of the RTP exposure that work. Continue to invest in and will. We love that exposure. RTP is on on fire with reshoring and onshoring capital. We extended it because the sponsors needed more capital. More capital and time to chase build the suit for a top seven market cap pharmaceutical company that's building a 350,000 square foot build the suit campus manufacturer. Training campus biomanufacturing campus there. So that's that's the reason for that one. Vacaville kind of goes along with my comments around edge compute sponsor there is working on a conversion of that biomanufacturing. facility to to an edge compute facility. The good news there is there's there's actually a solar field and and you know quite a bit of power there so we you know we're excited about the the opportunity to to invest in that project. and extend it and allow this business plan to take you know to take place because you know there's there's a lot of demand for that out there and we think it's an interesting way to to play the cycle.

  33. Thanks that's that's helpful on both those another chunky but I know you. guys have talked about him in the past as being very high quality. So just wanted to make sure I wasn't missing anything. And then to kind of piggyback on Jade's question about multi are there any. Maybe you guys mentioned this and I just missed it, but any any Mez or press. Positions where the seniors coming due or has been kind of getting close to full maturity extension where there may have to be some kind of workout where you guys may be getting the keys back.

  34. Not that we, nothing new. Honestly, we've already worked through a lot of that. I know that we pay attention to the rest of the calls and your guys. You know, analyses and questions and, you know, we were prepared to answer questions around delinquency and medicine prepositions, but whether there isn't really a ton, I'd say that.

  35. And like I said, the ability to kind of turn this on its face and play offense here, particularly with the agencies, is something we're extremely excited about. And the industry needs it. Like it's going to need. It's going to need to sliver capital coming in, particularly if the Fed continues to hike interest rates into this into this multi-cycle. So, yeah, nothing, nothing, you know, alarming at this point. Good to hear. Yeah. One final one, if I can sneak it in, is to that point, Matt, about solution capital, right, and to go forward and capital needs across multifamily. Where can you guys put money to work today? How different is it, at least from a return perspective for NREF relative to a year ago, two years ago, et cetera? Obviously, you have to be, capital can't be too expensive or it doesn't work for anybody in the stack. Just kind of give it over. Review of kind of where you can, if it's still kind of the same zip code of what you've been doing, a little higher, et cetera, would be helpful. Yeah, the, we could underwrite to high single digits with this, with the solution capital. And if we can do it with the agencies, then we can get back leverage on it like we have in the past. and into like a mid teens return. What I'd say is that the kind of return there, the return is still there. But what I think is now kind of coming home to roost is that the opportunities are starting to appear.

  36. You know, kind of heretofore, most folks were, most banks and, you know, non-bank lenders were willing to kind of hold through the cycle and, you know, just work it out themselves and, you know, maybe take on some REO. And sell it into a strengthening environment in 26 and 27. With the latest hike in interest rates, yeah, the exhaustion is starting to appear, I think, on some of these borrowers and sponsors and all. So some of the lenders. So I think that they're starting to be more open for the first time to ideas and solutions that we're bringing. So I think the return is going to be there. It's not going to be, you know. It's not going to be anything like to the depth of life science, but it is going to be an interesting place to play on a risk return profile. And it'll have some size. Like I said, we identified, you know, 30 billion. or so of opportunities. Thank you.

  37. Thanks, Ed.

  38. Operator

    Just a reminder, if you'd like to ask a question, please press star one to raise your hand.

  39. There are no further questions at this time.

  40. This concludes today's call.

  41. Thank you for.

  42. Operator

    for attending. You may now disconnect.

  43. Thanks everyone.

Replay